PHARMAORIGIN ApS: Financial statements 2012
CVR: 29178291
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -149,195. Equity in the 2012 report amounted to DKK 805,720. The solvency ratio was 16.3%.
- Profit/Loss
- DKK -149,195
- Equity
- DKK 805,720
- Total Assets
- DKK 4,943,772
Keep an eye on PHARMAORIGIN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of June 21, 2012, Lars Heslet has left the board of directors of PHARMAORIGIN ApS.
As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of PHARMAORIGIN ApS.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.